Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD-sEMG Guided Botulinum Neurotoxin for Chronic Pelvic Floor Pain
NCT06796985Phase 1Recruiting
- Sponsor
- University of Miami
- Start
- Feb 2025
- Primary completion
- Mar 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of botulinum neurotoxin in chronic pelvic pain (CPP) (2 arms), sponsored by University of Miami. Primary endpoint: Hypertonic index of the pelvic muscles. Started Feb 2025; status: recruiting.
02
Drugs
botulinum neurotoxin
03
Conditions
chronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT06796985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06796985.